In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

[Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Access to Frontline Health Care Act 
of 2011''.

SEC. 2. FRONTLINE PROVIDERS LOAN REPAYMENT PROGRAM.

    Part D of title III of the Public Health Service Act (42 U.S.C. 
254b et seq.) is amended--
            (1) by redesignating the second subpart XI (as added by 
        section 10333 of Public Law 111-148) as subpart XII;
            (2) by redesignating the second section 340H (as added by 
        such section 10333) as section 340I; and
            (3) by adding at the end the following:

             ``Subpart XIII--Frontline Health Care Services

``SEC. 340J. FRONTLINE PROVIDERS LOAN REPAYMENT PROGRAM.

    ``(a) In General.--The Secretary shall establish and carry out a 
Frontline Providers Loan Repayment Program (in this section referred to 
as the `Loan Repayment Program') under which, pursuant to contracts in 
accordance with this section--
            ``(1) the Secretary agrees to make student loan repayments; 
        and
            ``(2) the individual agrees to serve as a health 
        professional for a period of full-time service of not less than 
        2 years at a health care facility serving a frontline care 
        scarcity area.
    ``(b) Eligibility.--To be eligible to participate in the Loan 
Repayment Program, an individual must--
            ``(1) submit an application to participate in the Loan 
        Repayment Program in such form and manner and at such time as 
        specified by the Secretary; and
            ``(2) sign and submit to the Secretary, at the time of 
        submittal of such application, a written contract (described in 
        subsection (d)).
    ``(c) Participation in Program.--
            ``(1) In general.--An individual becomes a participant in 
        the Loan Repayment Program only upon the approval of the 
        Secretary of the individual's application submitted under 
        subsection (b)(1) and the Secretary's acceptance of the 
        contract submitted by the individual under subsection (b)(2).
            ``(2) Preference.--In awarding contracts under this 
        section, the Secretary shall give preference to applicants who 
        have undertaken training or coursework in interdisciplinary 
        studies.
            ``(3) Recruitment for interdisciplinary programs.--The 
        Secretary shall--
                    ``(A) determine the frontline care scarcity areas 
                in which to place contract recipients under this 
                section; and
                    ``(B) in making such determination, give preference 
                to areas with a demonstrated program of 
                interdisciplinary health care, or with demonstrated 
                plans to initiate interdisciplinary approaches to 
                community health care.
            ``(4) Notice.--The Secretary shall provide written notice 
        to an individual promptly upon the Secretary's approving, under 
        paragraph (1), of the individual's participation in the Loan 
        Repayment Program.
    ``(d) Contract.--The contract described in this subsection is a 
written contract between the Secretary and an individual that 
contains--
            ``(1) an agreement that--
                    ``(A) the Secretary agrees to provide the 
                individual with student loan repayment (described in 
                subsection (e)) for a period of time as determined by 
                the Secretary, to pay off debts incurred during the 
                course of the study or program described in subsection 
                (g)(2)(B); and
                    ``(B) the individual agrees--
                            ``(i) to accept provision of such a student 
                        loan repayment to the individual; and
                            ``(ii) to provide frontline care services 
                        for a period of full-time service of not less 
                        than 2 years at a health care facility serving 
                        a frontline care scarcity area;
            ``(2) a provision that any financial obligation of the 
        United States arising out of a contract entered into under this 
        section and any obligation of the individual which is 
        conditioned thereon, is contingent upon funds being 
        appropriated for student loan repayment under this section;
            ``(3) a statement of the damages to which the United States 
        is entitled, under subsection (f), for the individual's breach 
        of the contract; and
            ``(4) such other statements as the Secretary deems 
        appropriate of the rights and liabilities of the Secretary and 
        of the individual, not inconsistent with the provisions of this 
        section.
    ``(e) Student Loan Repayment.--
            ``(1) Amount.--The amount of an annual student loan 
        repayment under this section on behalf of an individual shall 
        be determined by the Secretary, and shall take into 
        consideration the need to pay a sufficient amount to enable 
        recruiting of health care providers into the loan repayment 
        program under this section.
            ``(2) Payments directly to loan provider.--The Secretary 
        may contract with an individual's loan provider, for the 
        payment to the loan provider, on behalf of the individual, of 
        the amounts of a student loan repayment described in paragraph 
        (1).
    ``(f) Breach of Contract.--If an individual breaches a written 
contract under this section by failing to begin such individual's 
service obligation, or to complete such service obligation, the United 
States shall be entitled to recover from the individual an amount that 
is equal to the sum of--
            ``(1) the total amount which has been paid to the 
        individual, or on behalf of the individual, under the contract; 
        and
            ``(2) any amount of interest, as determined by the 
        Secretary.
    ``(g) Definitions.--In this section:
            ``(1) The term `frontline care scarcity area' means an 
        area, population group, or facility that--
                    ``(A) is designated as a health professional 
                shortage area under section 332; or
                    ``(B) is designated by the State in which the area 
                is located as having a shortage of frontline care 
                services.
            ``(2) The term `frontline care services' means health care 
        services--
                    ``(A) in the field of general surgery, optometry, 
                ophthalmology, chiropractic, physical therapy, 
                audiology, speech language pathology, pharmacies, 
                public health, podiatric medicine, dietetics, 
                occupational therapy, general pediatrics, respiratory 
                therapy, medical technology, otolaryngology, or 
                radiologic technology; and
                    ``(B) provided by a general surgeon, optometrist, 
                ophthalmologist, chiropractor, physical therapist, 
                audiologist, speech language pathologist, pharmacist, 
                public health professional, podiatric physician, 
                registered dietician, occupational therapist, 
                pediatrician, respiratory therapist, medical 
                technologist, otolaryngologist, or radiologic 
                technologist who has completed an appropriate course of 
                study or program, offered by an accredited institution 
                of higher education in the United States.
    ``(h) Implementation.--The Secretary shall begin implementation of 
the loan repayment program under this section within 180 days of the 
date of the enactment of this section.''.
[A]: Access to Frontline Health Care Act of 2011 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services (HHS) to establish and carry out a Frontline Providers Loan Repayment Program under which the Secretary agrees to make student loan repayments in exchange for a health professional providing frontline care services for two years in a frontline care scarcity area. Defines "frontline care services" as health care services in the fields of general surgery, optometry, ophthalmology, chiropractic, physical therapy, audiology, speech language pathology, pharmacies, public health, podiatric medicine, dietetics, occupational therapy, general pediatrics, respiratory therapy, medical technology, otolaryngology, or radiologic technology.


[Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``United States-Israel Cybersecurity 
Cooperation Enhancement Act of 2016''.

SEC. 2. UNITED STATES-ISRAEL CYBERSECURITY COOPERATION.

    (a) Grant Program.--
            (1) Establishment.--The Secretary, in accordance with the 
        agreement entitled the ``Agreement between the Government of 
        the United States of America and the Government of the State of 
        Israel on Cooperation in Science and Technology for Homeland 
        Security Matters'', dated May 29, 2008 (or successor 
        agreement), and the requirements specified in paragraph (2), 
        shall establish a grant program at the Department to support--
                    (A) cybersecurity research and development; and
                    (B) demonstration and commercialization of 
                cybersecurity technology.
            (2) Requirements.--
                    (A) Applicability.--Notwithstanding any other 
                provision of law, in carrying out a research, 
                development, demonstration, or commercial application 
                program or activity that is authorized under this 
                section, the Secretary shall require cost sharing in 
                accordance with this paragraph.
                    (B) Research and development.--
                            (i) In general.--Except as provided in 
                        clause (ii), the Secretary shall require not 
                        less than 50 percent of the cost of a research, 
                        development, demonstration, or commercial 
                        application program or activity described in 
                        subparagraph (A) to be provided by a non-
                        Federal source.
                            (ii) Reduction.--The Secretary may reduce 
                        or eliminate, on a case-by-case basis, the 
                        percentage requirement specified in clause (i) 
                        if the Secretary determines that such reduction 
                        or elimination is necessary and appropriate.
                    (C) Merit review.--In carrying out a research, 
                development, demonstration, or commercial application 
                program or activity that is authorized under this 
                section, awards shall be made only after an impartial 
                review of the scientific and technical merit of the 
                proposals for such awards has been carried out by or 
                for the Department.
                    (D) Review processes.--In carrying out a review 
                under subparagraph (C), the Secretary may use merit 
                review processes developed under section 302(14) of the 
                Homeland Security Act of 2002 (6 U.S.C. 182(14)).
            (3) Eligible applicants.--An applicant shall be eligible to 
        receive a grant under this subsection if the project of such 
        applicant--
                    (A) addresses a requirement in the area of 
                cybersecurity research or cybersecurity technology, as 
                determined by the Secretary; and
                    (B) is a joint venture between--
                            (i)(I) a for-profit business entity, 
                        academic institution, National Laboratory (as 
                        defined in section 2 of the Energy Policy Act 
                        of 2005 (42 U.S.C. 15801)), or nonprofit entity 
                        in the United States; and
                            (II) a for-profit business entity, academic 
                        institution, or nonprofit entity in Israel; or
                            (ii)(I) the Federal Government; and
                            (II) the Government of Israel.
            (4) Applications.--To be eligible to receive a grant under 
        this subsection, an applicant shall submit to the Secretary an 
        application for such grant in accordance with procedures 
        established by the Secretary, in consultation with the advisory 
        board established under paragraph (5).
            (5) Advisory board.--
                    (A) Establishment.--The Secretary shall establish 
                an advisory board to--
                            (i) monitor the method by which grants are 
                        awarded under this subsection; and
                            (ii) provide to the Secretary periodic 
                        performance reviews of actions taken to carry 
                        out this subsection.
                    (B) Composition.--The advisory board established 
                under subparagraph (A) shall be composed of three 
                members, to be appointed by the Secretary, of whom--
                            (i) one shall be a representative of the 
                        Federal Government;
                            (ii) one shall be selected from a list of 
                        nominees provided by the United States-Israel 
                        Binational Science Foundation; and
                            (iii) one shall be selected from a list of 
                        nominees provided by the United States-Israel 
                        Binational Industrial Research and Development 
                        Foundation.
            (6) Contributed funds.--Notwithstanding any other provision 
        of law, the Secretary may accept or retain funds contributed by 
        any person, government entity, or organization for purposes of 
        carrying out this subsection. Such funds shall be available, 
        subject to appropriation, without fiscal year limitation.
            (7) Report.--Not later than 180 days after the date of 
        completion of a project for which a grant is provided under 
        this subsection, the grant recipient shall submit to the 
        Secretary a report that contains--
                    (A) a description of how the grant funds were used 
                by the recipient; and
                    (B) an evaluation of the level of success of each 
                project funded by the grant.
            (8) Classification.--Grants shall be awarded under this 
        subsection only for projects that are considered to be 
        unclassified by both the United States and Israel.
    (b) Termination.--The grant program and the advisory board 
established under this section terminate on the date that is seven 
years after the date of the enactment of this Act.
    (c) Prohibition on Additional Funding.--No additional funds are 
authorized to be appropriated to carry out this Act.
    (d) Definitions.--In this section--
            (1) the term ``cybersecurity research'' means research, 
        including social science research, into ways to identify, 
        protect against, detect, respond to, and recover from 
        cybersecurity threats;
            (2) the term ``cybersecurity technology'' means technology 
        intended to identify, protect against, detect, respond to, and 
        recover from cybersecurity threats;
            (3) the term ``cybersecurity threat'' has the meaning given 
        such term in section 102 of the Cybersecurity Information 
        Sharing Act of 2015 (enacted as title I of the Cybersecurity 
        Act of 2015 (division N of the Consolidated Appropriations Act, 
        2016 (Public Law 114-113)));
            (4) the term ``Department'' means the Department of 
        Homeland Security; and
            (5) the term ``Secretary'' means the Secretary of Homeland 
        Security.

            Passed the House of Representatives November 29, 2016.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
[A]: United States-Israel Cybersecurity Cooperation Enhancement Act of 2016  (Sec. 2) This bill requires the Department of Homeland Security (DHS) to establish a grant program to support cybersecurity research and development, and the demonstration and commercialization of cybersecurity technology, in accordance with the Agreement between the Government of the United States of America and the Government of the State of Israel on Cooperation in Science and Technology for Homeland Security Matters, dated May 29, 2008, or a successor agreement.  Grants may be awarded for social science research and technology intended to identify, protect against, respond to, and recover from cybersecurity threats. To be eligible for a grant, a project must be a joint venture between: (1) for-profit, nonprofit, or academic entities (including U.S. national laboratories) in the United States and Israel; or (2) the governments of the United States and Israel.  Grants shall be awarded only for projects considered unclassified by both the United States and Israel. DHS must require cost sharing of at least 50% from nonfederal sources for grant activities, but it may reduce the nonfederal percentage if necessary on a case-by-case basis.  DHS must establish an advisory board to monitor the impartial scientific and technical merit method by which grants are awarded and provide periodic reviews of the actions taken to carry out the program. The grant program terminates seven years after this bill's enactment. 


[Q]: SECTION 1. EXTENSION OF EXISTING SUSPENSION OF DUTY ON CERTAIN 
              CHEMICALS.

    Each of the following headings of the Harmonized Tariff Schedule of 
the United States is amended by striking ``12/31/92'' and inserting 
``12/31/94''.
            (1) 9902.29.04 (relating to p-Toluenesulfonyl chloride).
            (2) 9902.29.13 (relating to 2,6-Dichlorobenzaldehyde).
            (3) 9902.29.28 (relating to &lt;greek-a&gt;,&lt;greek-a&gt;,&lt;greek-a&gt;-
        Trifluoro-o-toluidine).
            (4) 9902.29.30 (relating to 8-Amino-1-naphthalenesulfonic 
        acid and its salts).
            (5) 9902.29.31 (relating to 5-Amino-2-(p-
        aminoanilino)benzenesulfonic acid).
            (6) 9902.29.33 (relating to 1-Amino-8-hydroxy-3,6-
        naphthalenedisulfonic acid; and 4-Amino-5-hydroxy-2,7-
        naphthalenedisulfonic acid, monosodium salt (H acid, monosodium 
        salt)).
            (7) 9902.29.35 (relating to 6-Amino-4-hydroxy-2-
        naphthalenesulfonic acid (Gamma Acid)).
            (8) 9902.29.38 (relating to 3,3'-Dimethoxybenzidine (o-
        Dianisidine) and its dihydrochloride).
            (9) 9902.29.40 (relating to 2-Amino-5-nitrophenol).
            (10) 9902.29.43 (relating to 1-Amino-2,4-
        dibromoanthraquinone).
            (11) 9902.29.44 (relating to 1-Amino-4-bromo-2-
        anthraquinonesulfonic acid (Bromamine acid) and its sodium 
        salt).
            (12) 9902.29.47 (relating to 4-Methoxyaniline-2-sulfonic 
        acid).
            (13) 9902.29.51 (relating to N-(7-Hydroxy-1-naphthyl 
        acetamide).
            (14) 9902.29.57 (relating to N,N-bis(2-cyanoethyl)aniline).
            (15) 9902.29.64 (relating to 6-(3-Methyl-5-oxo-1-
        pyrazolyl)-1,3-naphthalenedisulfonic acid (amino-J-pyrazolone) 
        (CAS No. 7277-87-4); and 3-Methyl-1-phenyl-5-pyrazolone 
        (Methylphenylpyrazolone).
            (16) 9902.29.69 (relating to 3-Methyl-5-pyrazolone).
            (17) 9902.29.79 (relating to 2-Amino-N-
        ethylbenzenesulfonoanilide).
            (18) 9902.30.15 (relating to 7-Hydroxy-1,3-
        naphthalenedisulfonic acid, dipotassium salt (CAS No. 842-18-
        2)).
            (19) 9902.30.18 (relating to 1,4-Dihydroxyanthraquinone 
        (CAS No. 81-64-1)).
            (20) 9902.30.31 (relating to 2-Chloro-4-nitroaniline (CAS 
        No. 121-87-9)).
            (21) 9902.30.32 (relating to 4-Chloro-&lt;greek-a&gt;-&lt;greek-a&gt;-
        &lt;greek-a&gt;-trifluoro-o-toluidine (CAS No. 445-03-4)).
            (22) 9902.30.34 (relating to 5-Amino-2-naphthalenesulfonic 
        acid (CAS No. 119-79-9)).
            (23) 9902.30.35 (relating to 7-Amino-1,3-
        naphthalenedisulfonic acid, monopotassium salt (CAS No. 842-15-
        9)).
            (24) 9902.30.36 (relating to 4-Amino-1-naphthalenesulfonic 
        acid, sodium salt (CAS No. 130-13-2)).
            (25) 9902.30.37 (relating to 8-Amino-2-naphthalenesulfonic 
        acid (CAS No. 119-28-8)).
            (26) 9902.30.38 (relating to mixtures of 5- and 8-amino-2-
        naphthalenesulfonic acid (CAS No. 119-28-8)).
            (27) 9902.30.39 (relating to 1-Naphthylamine (CAS No. 134-
        32-7)).
            (28) 9902.30.40 (relating to 6-Amino-2-naphthalenesulfonic 
        acid (CAS No. 93-00-5)).
            (29) 9902.30.43 (relating to 2,4-Diaminobenzenesulfonic 
        acid (CAS No. 88-63-1)).
            (30) 9902.30.48 (relating to 2-Amino-4-chlorophenol (CAS 
        No. 95-85-2)).
            (31) 9902.30.47 (relating to 1-Amino-2-methoxybenzene (o-
        Anisidine) (CAS No. 90-04-0)).
            (32) 9902.30.51 (relating to 7-Anilino-4-hydroxy-2-
        naphthalenesulfonic acid (CAS No. 119-40-4)).
            (33) 9902.30.52 (relating to 1,4-Diamino-2,3-
        dihydroanthraquinone (CAS No. 81-63-0)).
            (34) 9902.30.55 (relating to 1-Amino-2-bromo-4-
        hydroxyanthraquinone (CAS No. 116-82-5)).
            (35) 9902.30.67 (relating to 4-Aminoacetanilide (CAS No. 
        122-80-5)).
            (36) 9902.30.75 (relating to 2-[(4-
        Aminophenyl)sulfonyl]ethanol, hydrogen sulfate ester (CAS No. 
        2494-89-5)).
            (37) 9902.30.80 (relating to 2,5-Dichloro-4-(3-methyl-5-
        oxo-2-pyrazolin-1-yl)-benzenesulfonic acid (CAS No. 84-57-1)).
            (38) 9902.30.89 (relating to 1,3,3-Trimethyl-2-
        methyleneindoline (CAS No. 118-12-7)).
            (39) 9902.30.94 (relating to 7-Nitronaphth[1,2]-oxadiazole-
        5-sulphonic acid (CAS No. 84-91-3)).

SEC. 2. APPLICABILITY.

    (a) In General.--The amendments made by section 1 of this Act shall 
take effect on the 15th day after the date of the enactment of this 
Act.
    (b) Retroactive Provision.--Notwithstanding section 514 of the 
Tariff Act of 1930 or any other provision of law to the contrary, upon 
a request filed with the appropriate customs officer before the 90th 
day after the date of the enactment of this Act, any entry or 
withdrawal from warehouse for consumption of goods to which the 
amendment made by section 1 applies and that was made--
            (1) after December 31, 1992; and
            (2) before the 15th day after the date of the enactment of 
        this Act;
and with respect to which there would have been a lower duty if the 
amendment made by section 1 had applied to such entry or withdrawal, 
shall be liquidated or reliquidated as though such entry or withdrawal 
had occurred on such 15th day.
[A]:
Amends the Harmonized Tariff Schedule of the United States to extend, through December 31, 1994, the suspension of duty on certain chemicals.